Effective Factors in Door-to-Needle Time for Streptokinase Administration in Patients With Acute Myocardial Infarction Admitted to the Emergency Department
- PMID: 27218043
- PMCID: PMC4869426
- DOI: 10.5812/traumamon.19676
Effective Factors in Door-to-Needle Time for Streptokinase Administration in Patients With Acute Myocardial Infarction Admitted to the Emergency Department
Abstract
Background: Cardiovascular incidents are a common cause of death around the world. Acute myocardial infarction (AMI) poses high risks for the patient due to plaque rupture or erosion along with a superimposed non-occlusive thrombus; therefore, timely treatment with antithrombotic agents plays a key role in reducing an AMI mortality rate.
Objectives: The present study aimed to assess the time interval between the admission of AMI-suspected patients and treatment initiation.
Patients and methods: This cross-sectional study was conducted on 110 patients admitted to the emergency department of Imam Hussein hospital in Tehran, Iran. Data were collected using checklists, completed by the patients' next of kin or the emergency staff. To analyze the data, student t- test and analysis of variance were used.
Results: In this study, 31 female and 79 male subjects were included, respectively. The mean time to receive the first dose of streptokinase was 66.39 minutes (73.74 minutes for females and 63.5 minutes for male patients), varying from 49.92 minutes in the morning to 69.78 minutes in the afternoon and 72.68 minutes during night shifts.
Conclusions: The door-to-needle (DTN) time, in a standard setting, is recommended to be less than 30 minutes. According to the results of this study, the DTN time is comparatively two times longer in females and afternoon and night shifts. Different variables including emergency staff, physicians, patients' characteristics, and environmental/physical factors induced this difference.
Keywords: Acute Myocardial Infarction; Emergency Service; Needle Stick Injuries; Streptokinase.
Figures




Similar articles
-
Fibrinolytic administration for acute myocardial infarction in a tertiary ED: factors associated with an increased door-to-needle time.Am J Emerg Med. 2004 May;22(3):192-6. doi: 10.1016/j.ajem.2004.02.005. Am J Emerg Med. 2004. PMID: 15138955
-
Evaluation of fibrinolytic medical therapy for patients with acute myocardial infarction.ARYA Atheroscler. 2012 Spring;8(1):46-9. ARYA Atheroscler. 2012. PMID: 23056101 Free PMC article.
-
Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time.Heart. 2000 Aug;84(2):157-63. doi: 10.1136/heart.84.2.157. Heart. 2000. PMID: 10908251 Free PMC article.
-
Starting thrombolytic therapy for patients with acute myocardial infarction in Accident and Emergency Department: from implementation to evaluation.Chin Med J (Engl). 1998 Apr;111(4):291-4. Chin Med J (Engl). 1998. PMID: 10374389
-
Time to reperfusion in acute myocardial infarction. It is time to reduce it!J Electrocardiol. 2007 Jul;40(3):257-64. doi: 10.1016/j.jelectrocard.2007.01.007. J Electrocardiol. 2007. PMID: 17478179 Review.
Cited by
-
Recombinant Destabilase from Hirudo medicinalis Is Able to Dissolve Human Blood Clots In Vitro.Curr Issues Mol Biol. 2021 Nov 20;43(3):2068-2081. doi: 10.3390/cimb43030143. Curr Issues Mol Biol. 2021. PMID: 34889897 Free PMC article.
References
-
- Kloner RA, Dai W, Hale SL, Shi J. Approaches to Improving Cardiac Structure and Function During and After an Acute Myocardial Infarction: Acute and Chronic Phases. J Cardiovasc Pharmacol Ther. 2015 Nov 25; pii: 1074248415616187. [Epub ahead of print] - PubMed
-
- O'Rourke MF, Cook A, Carroll G, Gallagher D, Hall J. Accuracy of a portable interpretive ECG machine in diagnosis of acute evolving myocardial infarction. Aust N Z J Med. 1992;22(1):9–13. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources